PMID 17030830
For Alzheimer disease research, Dihexa has shown the most dramatic results
By purchasing, the buyer represents and warrants that the product will be used solely for in vitro research
Schedule: Daily subcutaneous injections for 812 weeks (extend to 16 weeks if desired), followed by a 24 week pause to resensitize receptors
Further, we reviewed how the gastrointestinal tract healing could be generally perceived (i) in terms of angiogenic growth factors, and/or (ii) through the healing of extragastrointestinal tissues healing, such as tendon, ligament, muscle and bone, and vice versa
However, recognising when symptoms warrant further assessment ensures safe, effective treatment